English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
 
 
DownloadE-Mail
  Identification and functional analysis of CITED2 mutations in patients with congenital heart defects

Sperling, S., Grimm, C. H., Dunkel, I., Mebus, S., Sperling, H.-P., Ebner, A., et al. (2005). Identification and functional analysis of CITED2 mutations in patients with congenital heart defects. Human Mutation, 26(6), 575-582. doi:10.1002/humu.20262.

Item is

Basic

show hide
Genre: Journal Article
Alternative Title : Hum Mutat

Files

show Files
hide Files
:
Sperling et al. - Human Mutation.pdf (Any fulltext), 244KB
Name:
Sperling et al. - Human Mutation.pdf
Description:
-
OA-Status:
Visibility:
Public
MIME-Type / Checksum:
application/pdf / [MD5]
Technical Metadata:
Copyright Date:
-
Copyright Info:
eDoc_access: PUBLIC
License:
-

Locators

show

Creators

show
hide
 Creators:
Sperling, Silke1, Author           
Grimm, Christina H.2, Author
Dunkel, Ilona3, Author           
Mebus, Siegrun, Author
Sperling, Hans-Peter, Author
Ebner, Arno, Author
Galli, Raffaello2, Author
Lehrach, Hans1, Author           
Fusch, Christoph, Author
Berger, Felix, Author
Hammer, Stefanie2, Author
Affiliations:
1Dept. of Vertebrate Genomics (Head: Hans Lehrach), Max Planck Institute for Molecular Genetics, Max Planck Society, ou_1433550              
2Max Planck Society, ou_persistent13              
3Computational Epigenetics (Ho-Ryun Chung), Independent Junior Research Groups (OWL), Max Planck Institute for Molecular Genetics, Max Planck Society, ou_1479658              

Content

show
hide
Free keywords: CITED2; congenital heart defects; CHD; septal defects; arterial malrotation
 Abstract: Recent reports have demonstrated that mice lacking the transcription factor Cited2 die in utero showing various cardiac malformations. We present for the first time functionally relevant mutations of CITED2 in patients with congenital heart defects (CHDs). CITED2 encodes a CREBBP/EP300 interacting transcriptional modulator of HIF1A and TFAP2. To study the potential impact of sequence variations in CITED2 for CHDs in humans, we screened a cohort of 392 well-characterized patients and 192 control individuals using DHPLC, sequencing, and AmplifluorTM genotyping techniques. We identified 15 CITED2 nucleotide alterations. Seven of these alterations were found only in CHD patients and were not detected in controls, including three mutations leading to alterations of the amino acid sequence (p.Ser170_Gly178del, p.Gly178_Ser179ins9, and p.Ser198_Gly199del). All three of these amino acid changing mutations cluster in the serine-glycine-rich junction of the protein, to which no functionality had heretofore been assigned. Here we show that these mutations significantly reduce the capacity of CITED2 to transrepress HIF1A, and that the p.Ser170_Gly178del mutation significantly diminishes TFAP2C coactivation. This reveals a modifying role for the serine-glycine-rich region in CITED2 function. In summary, the observation of these mutations in patients with septal defects indicates that CITED2 has a causative impact in the development of CHD in humans.

Details

show
hide
Language(s): eng - English
 Dates: 2005-11-14
 Publication Status: Issued
 Pages: -
 Publishing info: -
 Table of Contents: -
 Rev. Type: -
 Identifiers: eDoc: 275621
DOI: 10.1002/humu.20262
 Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show
hide
Title: Human Mutation
  Alternative Title : Hum Mutat
Source Genre: Journal
 Creator(s):
Affiliations:
Publ. Info: -
Pages: - Volume / Issue: 26 (6) Sequence Number: - Start / End Page: 575 - 582 Identifier: ISSN: 1059-7794